• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STERIS CORPORATION PROLYSTICA 2X CONCENTRATE ENZYMATIC PRESOAK AND CLEANER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STERIS CORPORATION PROLYSTICA 2X CONCENTRATE ENZYMATIC PRESOAK AND CLEANER Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Respiratory Distress (2045); Skin Irritation (2076); Chemical Exposure (2570)
Event Date 09/04/2014
Event Type  No Answer Provided  
Event Description
The user facility reported that steris detergents are causing lab technicians respiratory and skin irritations.
 
Manufacturer Narrative
Affected employees reported swollen tongues, itchy noses, light headedness, skin and respiratory irritations, and bad tastes in their mouths.The employees visited the employee health center; none of the employees were administered treatment and all returned to work the same day.A steris account manager spoke with user facility and identified the product as prolystica 2x concentrate enzymatic presoak and cleaner.The prolystica 2x concentrate enzymatic presoak and cleaner label states, "warning: contains subtilisins (proteolytic enzyme).Irritating to eyes and skin.Prolonged or frequently repeated contact to subtilisins may cause allergic reaction in some individuals.Do not breathe spray mist.Use adequate ventilation to maintain levels below established exposure limit." section 3.4.2 of ansi/aami st58:2005/(r)2010 regarding the ventilation of processing areas and equipment states, "general room ventilation: chemical sterilants should be used in an area that is properly ventilated.Rooms in which chemical disinfection and sterilization are performed should be large enough to ensure adequate dilution of vapor and should have a minimum air exchange rate of 10 air exchanges per hour (local regulations may require a higher minimum exchange rate).Ideally, local exhaust ventilation should be located at the level of the point of discharge of the vapors and pull vapors away from the work area and not toward personnel in the room." the steris account manager identified that the product was used in a confined space.The facility is currently conducting an evaluation of the ventilation of the space; the results have not yet been released.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROLYSTICA 2X CONCENTRATE ENZYMATIC PRESOAK AND CLEANER
Type of Device
CLEANER
Manufacturer (Section D)
STERIS CORPORATION
7501 page avenue
st. louis MO 63133
Manufacturer (Section G)
STERIS CORPORATION
7501 page avenue
st. louis MO 63133
Manufacturer Contact
kathryn cadorette
5960 heisley road
mentor, OH 44060
4403927231
MDR Report Key4140612
MDR Text Key4794671
Report Number1937531-2014-00009
Device Sequence Number1
Product Code FLG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 10/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Date Manufacturer Received09/04/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-